SCHEMBL16628686

SCHEMBL16628686

Nc1nc(C(=O)N2Cc3ccccc3C2)c2cc(O)ccc2n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 15/20 1.00
HSP90AB1 P08238 7/20 1.00
MAOB P27338 2/20 0.46
HSP90B1 P14625 2/20 0.43
TRAP1 Q12931 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628709 0.89 HSP90AA1 (0.80) HSP90AA1HSP90AB1HSP90B1TRAP1SMN1; SMN2
SCHEMBL3086700 0.89 HSP90AA1 (0.79) HSP90AA1HSP90AB1MAOBSMN1; SMN2HPGD
SCHEMBL16628713 0.88 HSP90AA1 (1.00) HSP90AA1HSP90AB1MAOBSMN1; SMN2HPGD
SCHEMBL12199578 0.86 HSP90AA1 (1.00) HSP90AA1HSP90AB1SMN1; SMN2HPGD
SCHEMBL903930 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1HSP90B1TRAP1SMN1; SMN2
SCHEMBL3085489 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1HSP90B1TRAP1SMN1; SMN2
SCHEMBL16628804 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1HSP90B1TRAP1SMN1; SMN2
SCHEMBL16628710 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1MAOBSMN1; SMN2
SCHEMBL3095799 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1SMN1; SMN2
SCHEMBL2505825 0.86 HSP90AA1 (0.76) HSP90AA1HSP90AB1HSP90B1TRAP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP disclosed